Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hierarchical Composite End Points: The Future of Randomized Trials of Kidney Disease?

Journal article

Staplin N. and Judge PK., (2026), Clin J Am Soc Nephrol

Population-scale repeat expansions elucidate disease risk and brain atrophy.

Journal article

Pounraja VK. et al, (2026), Nature

Postpartum anemia and maternal wellbeing: A cohort analysis of the WOMAN-2 trial.

Journal article

WOMAN‐2 Trial Collaborators ., (2026), Int J Gynaecol Obstet

Genetics of skeletal proportions across two different populations.

Journal article

Bartell E. et al, (2026), Am J Hum Genet, 113, 794 - 808

Stroke in China: advances in prevention and management on the path to a healthy China.

Journal article

Wu S. et al, (2026), Lancet Neurol, 25, 379 - 395

Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.

Journal article

Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1

The National Non-Hodgkin Lymphoma Audit: Insights and Impact.

Journal article

Kanani R. et al, (2026), Clin Oncol (R Coll Radiol), 52

Load More